Literature DB >> 8131742

Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism.

J W Peacock1, S Benchimol.   

Abstract

Rat embryo fibroblasts transformed with the HPV-16 E7 gene and the activated c-H-ras gene fall into two distinct phenotypic classes. At high cell density, clones of one class form colonies in methylcellulose supplemented with low serum; at low cell density, these cells display responsiveness to mitogenic factors present in serum-free conditioned medium from rat embryo fibroblasts. In contrast, clones of the second class exhibit an absolute dependency on growth factors present in serum at all cell densities in the methylcellulose colony assay and fail to respond to conditioned medium. We find that the status of the endogenous p53 gene is tightly correlated with these two classes of clones. Clones of the first class contain missense mutations in the p53 gene and have lost the wild-type allele. Clones of the second class express wild-type p53 protein. The importance of mutant p53 expression in reducing the growth factor dependency of transformed clones was confirmed in a separate series of experiments in which rat embryo fibroblasts were transformed with three genes, E7 + ras + mutant p53. The growth behaviour of these triply transfected clones was similar to that of the E7 + ras clones expressing endogenous mutant p53. We demonstrate that the enhanced proliferation of E7 + ras clones expressing mutant p53 protein involves an autocrine mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131742      PMCID: PMC394917          DOI: 10.1002/j.1460-2075.1994.tb06357.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  66 in total

1.  p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells.

Authors:  S R Rittling; D T Denhardt
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

2.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.

Authors:  C A Finlay; P W Hinds; T H Tan; D Eliyahu; M Oren; A J Levine
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

4.  Thymocyte apoptosis induced by p53-dependent and independent pathways.

Authors:  A R Clarke; C A Purdie; D J Harrison; R G Morris; C C Bird; M L Hooper; A H Wyllie
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

5.  p53 is required for radiation-induced apoptosis in mouse thymocytes.

Authors:  S W Lowe; E M Schmitt; S W Smith; B A Osborne; T Jacks
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

6.  Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.

Authors:  R R Berges; Y Furuya; L Remington; H F English; T Jacks; J T Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

7.  Gain of function mutations in p53.

Authors:  D Dittmer; S Pati; G Zambetti; S Chu; A K Teresky; M Moore; C Finlay; A J Levine
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

8.  Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.

Authors:  B Rovinski; S Benchimol
Journal:  Oncogene       Date:  1988-05       Impact factor: 9.867

9.  Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours.

Authors:  T Crook; D Wrede; J A Tidy; W P Mason; D J Evans; K H Vousden
Journal:  Lancet       Date:  1992-05-02       Impact factor: 79.321

10.  Comparison of the in vitro transforming activities of human papillomavirus types.

Authors:  A Storey; D Pim; A Murray; K Osborn; L Banks; L Crawford
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  4 in total

1.  Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors.

Authors:  P Auewarakul; L Gissmann; A Cid-Arregui
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

2.  The p53-mediated G1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras.

Authors:  J W Peacock; S Chung; R G Bristow; R P Hill; S Benchimol
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

3.  Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures.

Authors:  Xichen Zhang; Wen Hou; Michael W Epperly; Lora Rigatti; Hong Wang; Darcy Franicola; Aranee Sivanathan; Joel S Greenberger
Journal:  Oncotarget       Date:  2016-10-18

4.  p53 antisense oligonucleotide inhibits growth of human colon tumor and normal cell lines.

Authors:  Y Hirota; T Horiuchi; K Akahane
Journal:  Jpn J Cancer Res       Date:  1996-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.